Skip to main content

Breadcrumb

  1. Home

Spring 2014

Median Time to Pain Management for Long Bone Fracture

Median time from emergency department arrival to time of initial oral, intranasal or parenteral pain medication administration for emergency department patients with a principal diagnosis of long bone fracture (LBF).

CBE ID
0662

Methotrexate: CBC within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a CBC test within 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim

CBE ID
0598

Methotrexate: Creatinine within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a serum creatinine test in the 120 days (3 months + 1 month grace period) after the earliest observed methotrexate prescription claim.

CBE ID
0599

Methotrexate: LFT within 12 weeks

This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a liver function test (LFT) in the 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim.

CBE ID
0597

New Rheumatoid Arthritis Baseline ESR or CRP within Three Months

This measure identifies adult patients newly diagnosed with rheumatoid arthritis during the first 8 months of the measurement year who received erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) lab tests either 4 months (3 months + 1-month grace period) before or after the initial diagnosis.

CBE ID
0601

Osteoarthritis: Function and Pain Assessment

Type of score: Proportion
Percentage of patient visits for patients aged 21 years and older with a diagnosis of osteoarthritis with assessment for function and pain

CBE ID
0050